Our results here indicate that SNX8 levels are attenuated in human AD and mouse APP/PS1 AD models; SNX8 mediates APP trafficking from amyloidogenic endosomal compartments, and suppresses Aβ generation and cognitive impairment in APP/PS1 mice. This evidence concerns the gene APP and Alzheimer disease.